Tag: NYSE:LLY

Finance

Investor’s Alert: Intel Corporation (NASDAQ:INTC), Exxon Mobil (NYSE:XOM), Kodiak Oil & Gas (NYSE:KOG), Marathon Oil (NYSE:MRO), Eli Lilly (NYSE:LLY)

Intel Corporation (NASDAQ:INTC) today announced new details for its next-generation Intel Xeon Phi processors, code-named Knights Landing, which promise to extend the benefits of code modernization investments being made for current generation products. These include a new high-speed fabric that will be integrated on-package and high-bandwidth, on-package memory that combined, promise to accelerate the rate of scientific discovery.  Intel Corporation (NASDAQ:INTC) stock performance was 0.10% … Continue reading Investor’s Alert: Intel Corporation (NASDAQ:INTC), Exxon Mobil (NYSE:XOM), Kodiak Oil & Gas (NYSE:KOG), Marathon Oil (NYSE:MRO), Eli Lilly (NYSE:LLY)

Kevin Long
Finance

Health Stocks to Watch: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD), Eli Lilly (NYSE:LLY)

Earlier this month, Vivus Inc. (NASDAQ:VVUS) said it filed a patent-infringement lawsuit against Actavis PLC ( ACT ) alleging that the drug maker’s planned generic version of weight-loss drug Qsymia infringes its patents. VIVUS, Inc. (NASDAQ:VVUS) stock performance was 3.97% in last session and finished the day at $5.50. Traded volume was 4.47million shares in the last session and the average volume of the stock remained 3.04million … Continue reading Health Stocks to Watch: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD), Eli Lilly (NYSE:LLY)

John Meady
Finance

Healthcare ACtive Stocks: Rexahn Pharmaceuticals (NYSEMKT:RNN), Eli Lilly (NYSE:LLY), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD), Gentiva Health Services (NASDAQ:GTIV)

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) said, “We continue to enroll patients in each of our three clinical trials as expected, and as planned for. By the end of 2014, we expect to achieve key milestones in each trial. In Q4 we expect to have data from our Phase I trial of Supinoxin in cancer patients with solid tumors. We are also scheduled to complete enrollment of … Continue reading Healthcare ACtive Stocks: Rexahn Pharmaceuticals (NYSEMKT:RNN), Eli Lilly (NYSE:LLY), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD), Gentiva Health Services (NASDAQ:GTIV)

Colin Pettis
Finance, Internet

Stocks in Focus : Liberty Interactive Corp (NASDAQ:LVNTA)

On Dec 01, Eli Lilly and Company (NYSE:LLY) and AstraZeneca announced enrollment of the first patient into Amaranth, a Phase 2/3 study of an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer’s disease. Eli Lilly and Company (NYSE:LLY) belongs to Healthcare sector. Its net profit margin is 13.20% and weekly performance is 7.52%. On last trading day … Continue reading Stocks in Focus : Liberty Interactive Corp (NASDAQ:LVNTA)

Kevin Long
Finance

Big Movers : NewLink Genetics Corporation (NASDAQ:NLNK), Southern Company (NYSE:SO), Castlight Health, Inc. (NYSE:CSLT), Eli Lilly and Company (NYSE:LLY), eBay Inc. (NASDAQ:EBAY)

On Oct 13, Human testing of an experimental Ebola vaccine developed by the Canadian health agency and licensed to NewLink Genetics Corporation (NASDAQ:NLNK)has begun, Canadian health minister Rona Ambrose said. NewLink Genetics Corporation (NASDAQ:NLNK) belongs to Healthcare sector. Its weekly performance is 72.27%. On last trading day company shares ended up $31.87. NewLink Genetics Corporation (NASDAQ:NLNK) distance from 50-day simple moving average (SMA50) is 29.39%. … Continue reading Big Movers : NewLink Genetics Corporation (NASDAQ:NLNK), Southern Company (NYSE:SO), Castlight Health, Inc. (NYSE:CSLT), Eli Lilly and Company (NYSE:LLY), eBay Inc. (NASDAQ:EBAY)

Adam Keintzel
Finance

Moving Stocks : Analog Devices, Inc. (NASDAQ:ADI), SunEdison, Inc. (NYSE:SUNE), Calumet Specialty Products Partners LP (NASDAQ:CLMT), Eli Lilly and Company (NYSE:LLY), Magna International (NYSE:MGA)

Analog Devices (NYSE:ADI) had its target price decreased by Oppenheimer from $61.00 to $55.00 in a research note released on Tuesday morning. They currently have an outperform rating on the stock. Analog Devices, Inc. (NASDAQ:ADI) belongs to Technology sector. Its net profit margin is 32.10% and weekly performance is -3.75%. On last trading day company shares ended up $44.60. Analog Devices, Inc. (NASDAQ:ADI) distance from … Continue reading Moving Stocks : Analog Devices, Inc. (NASDAQ:ADI), SunEdison, Inc. (NYSE:SUNE), Calumet Specialty Products Partners LP (NASDAQ:CLMT), Eli Lilly and Company (NYSE:LLY), Magna International (NYSE:MGA)

Mark Doerr